Icotinib Hydrochloride
Product Specifications
CAS Number
1204313-51-8
Target
EGFR
Related Pathways
Tyrosine Kinase/Adaptors, JAK/STAT signaling, Angiogenesis
Purity
0.9989
Bioactivity
Icotinib Hydrochloride (BPI-2009H) is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineoplastic activity. Icotinib selectively inhibits the wild-type and several mutated forms of EGFR tyrosine kinase. This may lead to an inhibition of EGFR-mediated signal transduction and may inhibit cancer cell proliferation. EGFR, a receptor tyrosine kinase, has been upregulated in a variety of cancer cell types.
Smiles
Cl.C#Cc1cccc(Nc2ncnc3cc4OCCOCCOCCOc4cc23)c1
Molecular Formula
C22H22ClN3O4
Molecular Weight
427.88
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
221351-01 50 µL
Caspase 9 (CASP 9, Caspase9, Caspase-9, CASP-9, Apoptotic Protease Mch-6, Apoptotic Protease-Activating Factor 3, APAF-3, ICE-like Apoptotic Protease 6, ICE-LAP6, Caspase-9 Subunit p35, Caspase-9 Subunit p10, CASP9, MCH6) discontinued
Sign In for Pricing
View Details 221351-02 100 µL
Caspase 9 (CASP 9, Caspase9, Caspase-9, CASP-9, Apoptotic Protease Mch-6, Apoptotic Protease-Activating Factor 3, APAF-3, ICE-like Apoptotic Protease 6, ICE-LAP6, Caspase-9 Subunit p35, Caspase-9 Subunit p10, CASP9, MCH6) discontinued
Sign In for Pricing
View Details 
Z01LS-1022-LS337 5 Plates
Mouse FGFR4 Matched Antibody Pair Set (RC18/RD19)
Sign In for Pricing
View Details MBS2119804-01 0.1 mL
APC-Linked Polyclonal Antibody to Complement Component 4 (C4)
Sign In for Pricing
View Details MBS2119804-02 0.2 mL
APC-Linked Polyclonal Antibody to Complement Component 4 (C4)
Sign In for Pricing
View Details